Insulet (NSDQ:PODD) hosted a ribbon cutting ceremony today to open its new global headquarters and manufacturing facility in Acton, Mass.
The new facility is part of a $200 million investment in Massachusetts and is located on 26 acres of land. The site’s groundbreaking ceremony took place a year and a half ago and the investment has created hundreds of jobs locally and is expecting to drive operating efficiencies and increase productivity for its growing U.S. customer base.
Gov. Charlie Baker attended the event, along with company president and CEO Shacey Petrovic, former CEO Pat Sullivan and executive VP and chief operating officer Chuck Alpuche. Massachusetts State Sen. Jamie Eldridge, president and CEO of Massachusetts Life Sciences Center Travis McCready were also in attendance.
At the ribbon-cutting ceremony, Petrovic described the new facility as a “true operational center of excellence.”
“We had to think big to support our rapid growth,” Alpuche said during the event. “It was bold, it was cutting edge and thinking back on it, maybe it was a little crazy. But we have done it.”
“As a global hub for innovation and research, Massachusetts is well-positioned to expand its advanced manufacturing footprint,” Gov. Charlie Baker said in prepared remarks. “Our Administration has prioritized efforts to create an environment that supports the growth of companies like Insulet, and we are glad to see them open this new facility and create jobs here in the Commonwealth.”
The opening of the new facility comes in the midst of Insulet launching its new Omnipod Dash system that wirelessly connects the company’s Personal Diabetes Manager with its tubeless, waterproof insulin pump.
